期刊文献+

黄芪皂苷Ⅳ通过PKA途径减轻缺氧/复氧心肌损伤的机制研究 被引量:6

The mechanism of astragaloside IV alleviation of hypoxia/reoxygenation induced cultured cardiomyocyte injury via PKA pathway
下载PDF
导出
摘要 目的:研究黄芪皂苷IV(astragaloside IV,As-IV)减轻缺氧/复氧所致心肌细胞损伤的机制。方法:胰酶多次消化法培养新生SD大鼠原代心肌细胞,建立缺氧/复氧模型,测定培养心肌细胞上清心肌损伤标志物肌酸激酶同工酶(creatine kinase,CK-MB)含量,检测心肌细胞肌浆网钙ATP酶(sarcoplasmic reticulum Ca2+-ATPase,SERCA2a)活性、Real-Time PCR法测定PKA催化亚单位α(PKA C subunitα,PKA-Cα)基因的表达水平以及Western blot检测第16位丝氨酸磷酸化受磷蛋白(Ser16 phos-phorylated phospholamban,Ser16-PLN)的表达水平,同时以As-IV(30μmol/L)干预,观察其作用。结果:与正常组相比,缺氧/复氧(hypoxia/reoxygenation,H/R)引起心肌细胞CK-MB释放增加,SERCA2a活性降低约35%、PKA-Cα基因表达下调28%以及Ser16-PLN表达下调51%,P值均﹤0.05,As-IV干预则可逆转上述变化,基本恢复至正常水平。结论:黄芪皂苷Ⅳ抑制缺氧/复氧所致心肌细胞损伤的机制可能是通过上调PKA-Cα基因表达,提高受磷蛋白(phosphorylated phospholamban,PLN)16位丝氨酸的磷酸化水平,解除PLN对SERCA2a的抑制,从而增强SERCA2a的功能。 Objective: To investigate the mechanism of astragaloside IV(As-IV) on alleviation of hypoxia/reoxygenation induced myocardial injury.Methods: Cultured cardiomyocytes from neonatal SD rats were exposed to 6 h of hypoxia followed by 3 h of reoxygenation(H/R).Meanwhile,As-IV(30 ?滋mol/L) was treated in H/R cardiomyocytes.Myocytes injury was determined by the release of creatine kinase(CK-MB) in supernatant.Myocardial SERCA2a activity was measured,PKA C subunit α(PKA-Cα) gene expression and Ser16 phosphorylated phospholamban(Ser16-PLN) protein expression level were detected by real-time PCR and Western blot respectively.Results: Cultured cardiomyocytes exposed to hypoxia/reoxygenation presented statistically higher CK-MB in supernatant,decreased myocardial SERCA2a activity,reduced PKA-Cα gene and Ser16-PLN protein expressions(P 0.05).But As-IV treatment significantly prevented the alterations in H/R cardiomyocytes mentioned above.Conclusion: These results suggest that the cardioprotective effects of As-IV may be associated with upregulation of PKA-Cα gene and Ser16-PLN protein expressions,thus restoring the SERCA2a function in hypoxia/reoxygenation injury.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第1期30-34,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金项目(30772781 30770894)
关键词 黄芪皂苷Ⅳ 心肌保护 肌浆网钙ATP酶 PKA 受磷蛋白 astragaloside IV cardioprotection sarcoplasmic reticulum calcium ATPase PKA phosphorylated phospholamban
  • 相关文献

参考文献4

二级参考文献54

  • 1苏丹,马春来,吴大正,周吉燕,胡之璧.氯沙坦和雷米普利对压力过载引起的左心室肥厚作用的比较观察[J].中国新药与临床杂志,2006,25(5):353-358. 被引量:3
  • 2崔伊梅,于明欣,高卫真,刘艳霞.黄芪苷Ⅳ对阿霉素损伤培养乳鼠心肌细胞保护作用机制研究[J].中国药理通讯,2006,23(3):36-37. 被引量:3
  • 3江凤林,冯俊,郑智.丹参酮ⅡA对AngⅡ诱导的心肌肥大中c-fos、c-myc和c-jun mRNA表达的影响[J].中国药理学通报,2007,23(1):55-59. 被引量:13
  • 4Hill J A,Olson E N.Cardiac plasticity[J].New England J Med,2008,358(13):1370-80.
  • 5Xu X L,Chen X J,Ji H,et al.Astragaloside Ⅳ improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca2+-ATPase[J].Pharmacology,2008,81(4):325-32.
  • 6Zhang Z C,Li S J,Yang Y Z,et al.Effect of astragaloside on cardiomyocyte apoptosis in murine coxsackievirus B3 myocarditis[J].J Asian Nat Prod Res,2007,9(2):145-51.
  • 7Zhang Z C,Li S J,Yang Y Z.Effect of astragaloside on myocardial fibrosis in chronic myocarditis[J].Chin J Integr Tradit West Med,2007,27(8):728-31.
  • 8Dhalla N S,Saini-Chohan H K,Rodriguez-Leyva D,et al.Subcellular remodelling may induce cardiac dysfunctionin congestive heart failure[J].Cardiovasc Res,2009,81(3):429-38.
  • 9Kawase Y,Hajjar R J.The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase:a potent target for cardiovascular diseases[J].Nat Clin Pract Cardiovasc Med,2008,5(9):554-65.
  • 10Kaye D M,Hoshijima M,Chien K R.Reversing advanced heart failure by targeting Ca^2+ cycling[J].Annu Rev Med,2008,59:13-28.

共引文献64

同被引文献89

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部